Print

2018 Top Story

- Archives -

Physician-scientist Jane Freedman focuses on improving cardiovascular health

Physician-scientist Jane Freedman focuses on improving cardiovascular health

The single-minded goal of cardiologist and scientist Jane Freedman, MD, is to seek insights that will help heal patients with heart disease. Learn about her research and career in the latest Women in Science video.

UMMS licenses clinical-stage gene therapies for Tay-Sachs, similar diseases to Axovant

UMMS licenses clinical-stage gene therapies for Tay-Sachs, similar diseases to Axovant

Axovant Sciences, a Swiss company developing gene therapies for neurological diseases, has licensed exclusive worldwide rights for the development and commercialization of two novel gene therapy programs for Tay-Sachs and Sandhoff diseases from UMassMedical School. 

UMMS scientists receive $1.6M in NIH funding to improve genome editing techniques

UMMS scientists receive $1.6M in NIH funding to improve genome editing techniques

Led by Guangping Gao, PhD, and Erik Sontheimer, PhD, scientists at UMass Medical School will work to develop technology to enable safe genome editing in patients, thanks to new grant funding from the National Institutes of Health.

NIH grant supports UMMS research on ‘off switch’ for extra chromosome in Down syndrome

NIH grant supports UMMS research on ‘off switch’ for extra chromosome in Down syndrome

Jeanne Lawrence, PhD, and Jaime Rivera, PhD, received a five-year, $2.8 million grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development at the National Institutes of Health to test a strategy in a mouse model for silencing the extra chromosome that causes Down Syndrome.

Victor Ambros named fellow of the American Association for the Advancement of Science

Victor Ambros named fellow of the American Association for the Advancement of Science

Victor Ambros, PhD, has been elected by his peers as a fellow of the American Association for the Advancement of Science.

RNAi therapy mitigates preeclampsia symptoms in UMass Medical School study

RNAi therapy mitigates preeclampsia symptoms in UMass Medical School study

A new study by Anastasia Khvorova, PhD, and Melissa Moore, PhD, at UMass Medical School and colleagues at Beth Israel Deaconess Medical Center and Western Sydney University, suggests that RNA interference therapy could be a potential strategy for the treatment of preeclampsia.

In their own words: Matilde Castiel, Naheed Usmani share personal immigration stories

In their own words: Matilde Castiel, Naheed Usmani share personal immigration stories

Matilde Castiel, MD, and Naheed Usmani, MD, shared their personal journeys of coming to the United States at the debut of the UMass Immigrant Stories series on Wednesday, Nov. 14.

UMMS developing training program on medication-assisted opioid addiction treatment

UMMS developing training program on medication-assisted opioid addiction treatment

The Substance Abuse and Mental Health Services Administration has awarded a grant to UMass Medical School to create a training program that will qualify medical, nurse practitioner and physician assistant students to provide medication-assisted treatment for opioid-addicted patients. Daniel Mullin, PsyD, is principal investigator on the grant.

Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial

Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial

The Toronto-based Blu Genes Foundation, which is dedicated to developing gene therapies for rare disease, has given $1.4 million to UMass Medical School to advance a Phase I/II clinical trial for Tay-Sachs. Miguel Sena-Esteves, PhD, Terence Flotte, MD, Heather Gray-Edwards, PhD, DVM, and colleagues at  Auburn University are leading the research.

Commonwealth of Massachusetts Employee Charitable Campaign kicks off

Commonwealth of Massachusetts Employee Charitable Campaign kicks off

The annual Commonwealth of Massachusetts Employee Charitable Campaign kicks off at UMass Medical School on Monday, Nov. 5. The statewide campaign allows UMMS employees to contribute to any of more than 1,000 screened nonprofit organizations that support a wide range of needs. 

Showing 1-10 of 111 items
of 12